Not long ago, building a production-grade AI agent system meant months of engineering work before a single line of business logic got written. You needed distri
In 2026, NMN entered its first clinical trial for autoimmune disease and appeared in Nature Medicine. Combined with new evidence on T cell senescence reversal and exercise-driven SIRT1 activation, three studies map NAD+ as an immune calibrator.
A few years ago, a startup was charging people tens of thousands of dollars to infuse them with plasma from young donors. The FDA eventually issued a statement:
There's a contradiction sitting at the center of anti-aging biology that doesn't get explained enough: some researchers are working hard to increase autophagy
Mechanical ventilation is one of modern medicine's most important life-saving tools. For patients in respiratory failure, it is the bridge between death and sur
Most people know that poor sleep makes them feel older. But does it actually make them biologically older — in a way measurable in their blood?A 2026 systemat
Age-related macular degeneration — in its dry form — has no approved treatment that meaningfully stops its progression. It affects tens of millions of people wo
Most anti-aging narratives focus on fuel. Add more NAD+. Supplement more precursors. Keep the cellular engine running.A 2026 paper in Phytomedicine asks a dif
The supplement industry has a gift for turning a promising molecule into a simple story: your NAD+ declines with age, so you take a precursor like NMN or NR to
An open-source recursive LLM-powered investigation agent that performs entity resolution across heterogeneous datasets (corporate filings, campaign finance, government contracts) and renders knowledge graphs in real-time via Cytoscape.js. Built with Tauri 2, MIT licensed, positioned as Palantir's community edition. 1,600 Stars in two months.
Please do not include confidential, unpublished or personal data. Messages are relayed to our team via LINE and kept for 30 days.